HLN

Haleon plc NYSE Listed Jul 25, 2022

Healthcare ·Drug Manufacturers - Specialty & Generic ·GB · haleon.com

$9.30

Mkt Cap $41.3B

52w Low $8.71 22.0% of range 52w High $11.42

50d MA $9.92 200d MA $9.80

P/E (TTM) 26.1x

EV/EBITDA 14.7x

P/B 2.5x

Debt/Equity 0.5x

ROE —

P/FCF 17.1x

RSI (14) —

ATR (14) —

Beta 0.33

50d MA $9.92

200d MA $9.80

Avg Volume 8.1M

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

SIC Code

2844

CIK (SEC)

1900304

Phone

44 1932 822000

Building 5 · Weybridge, X0 KT13 0NY · GB

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 25, 2026	AMC	0.25	0.26	+3.4%	10.44	+2.9%	+3.1%	+2.9%	-1.8%	-2.4%	-1.3%	—
Oct 30, 2025	AMC	0.24	0.14	-42.8%	9.18	+0.4%	+1.0%	+1.2%	-0.6%	-0.1%	+1.1%	—
Aug 7, 2025	AMC	0.24	0.08	-67.3%	9.46	+0.3%	+0.8%	-0.7%	+1.2%	+1.1%	+0.1%	—
Feb 27, 2025	AMC	25.25	0.05	-99.8%	9.79	+4.2%	+4.0%	+3.9%	+0.9%	-1.2%	-1.4%	—
Oct 31, 2024	AMC	0.11	0.14	+27.3%	9.69	+1.1%	+0.4%	+0.3%	+0.1%	-2.4%	+0.6%	—
May 1, 2024	AMC	0.11	0.12	+9.1%	8.35	-0.8%	-0.4%	-0.2%	-0.7%	+1.1%	-1.7%	—
Feb 29, 2024	AMC	10.27	6.54	-36.3%	8.56	-1.5%	-1.3%	-1.7%	+0.2%	+0.0%	+2.6%	—
Aug 2, 2023	AMC	0.22	0.08	-63.5%	8.32	+0.0%	+0.6%	-1.3%	+1.3%	+0.5%	+0.8%	—
Mar 2, 2023	AMC	0.23	0.21	-9.7%	7.63	+0.8%	+1.8%	+1.0%	-0.9%	+0.1%	-0.6%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 23	Barclays	Upgrade	Equal Weight → Overweight	—	$10.33	$10.36	+0.3%	+1.3%	-0.9%	+0.5%	-1.1%	-0.1%
Sep 16	Barclays	Downgrade	Overweight → Equal Weight	—	$9.68	$9.35	-3.4%	-4.1%	+1.3%	-1.7%	-0.9%	-1.7%
Sep 20	Morgan Stanley	Maintains	Overweight → Overweight	—	$10.46	$10.45	-0.1%	+0.6%	+1.0%	+0.3%	-0.7%	+0.0%
Mar 26	Argus	Maintains	Buy → Buy	—	$8.43	$8.41	-0.2%	-0.2%	+1.4%	-0.5%	-1.8%	-0.7%
Apr 6	Argus	Upgrade	Hold → Buy	—	$8.63	$8.81	+2.1%	+3.9%	-1.3%	-0.9%	+0.7%	-0.9%
Sep 28	Argus	Maintains	Hold → Hold	—	$5.85	$5.86	+0.2%	+2.2%	+2.2%	-0.3%	+0.8%	+1.6%
Jul 29	Deutsche Bank	Maintains	Hold → Hold	—	$7.00	$6.92	-1.1%	+0.4%	+4.8%	+0.4%	-1.4%	+0.1%

Data updated apr 26, 2026 10:51am · Source: massive.com